Skip to Main Content

1,262

Views

0

CrossRef citations to date

0

Altmetric

Review

Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials

Rish K. Paia Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USACorrespondence[email protected]
View further author information

,

Geert D’Haensb Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam University Medical Centers, Amsterdam, NetherlandsView further author information

,

Taku Kobayashic Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, JapanView further author information

,

Bruce E. Sandsd Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USAView further author information

,

Simon Travise Kennedy Institute and Biomedical Research Centre, University of Oxford, Oxford, UKView further author information

,

Vipul Jairathf Division of Gastroenterology, Schulich School of Medicine and Dentistry, Western University, London, ON, CanadaView further author information

,

Gert De Hertoghg Department of Pathology, University Hospitals Leuven, Leuven, BelgiumView further author information

,

Bomina Parkh Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Kim McGinnish Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Isabel Redondoh Eli Lilly and Company, Indianapolis, IN, USAView further author information

,

Nicole G. Lipitzi Syneos Health, San Diego, CA, USAView further author information

,

Theresa Hunter Gibbleh Eli Lilly and Company, Indianapolis, IN, USAView further author information

&

Fernando Magroj CINTESIS@RISE, Departmento, Faculty of Medicine of the University of Porto, Porto, PortugalView further author information